Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03669939 · ClinicalTrials.gov registry record
Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 42
- Enrollment target
NCT03669939 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 42 participants.
The verdict
NCT03669939 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The overarching plan for TOWER is to develop and test an algorithmic version of the Center for Disease Control Guidelines (CDCG) tailored for a specific primary care setting, the HIV primary care clinic. This CDCG intervention incorporates communication and implementation strategies tailored for the HIV primary care setting, and enabled with technology (an app for use by patients and EMR tools for providers).
Interventions
- OTHER Standard of Care
- OTHER Communication Strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2018-10-05 |
| Est. Completion | 2020-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03669939
The ClinicalTrials.gov registry entry for NCT03669939 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT03669939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03669939 about?
NCT03669939 is a clinical study titled "Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations". The overarching plan for TOWER is to develop and test an algorithmic version of the Center for Disease Control Guidelines (CDCG) tailored for a specific primary care setting, the HIV primary care clinic. This CDCG intervention incorporates communication and implementation strategies tailored for the...
What is the current status of trial NCT03669939?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2018-10-05. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT03669939?
The interventions under investigation include: Standard of Care (OTHER), Communication Strategy (OTHER).
Who is sponsoring clinical trial NCT03669939?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.